3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Neoplasm Metastasis
1
Meningioma
1
Glioma
1
Central Nervous System Vascular Malformations
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Aneurysm
1
Interventions
HhAntag691
21
Biopsy
11
Imiquimod
10
Aminolevulinic Acid
9
sonidegib
8
Photochemotherapy
8
Nivolumab
8
1-phenyl-3,3-dimethyltriazene
7
methyl 5-aminolevulinate
6
cemiplimab
6
Surgical Procedures, Operative
5
Specimen Handling
5
Radiotherapy
5
Itraconazole
5
pembrolizumab
4
daromun
4
Mohs Surgery
4
Magnetic Resonance Spectroscopy
4
Ipilimumab
4
Curettage
4
Tomography, Optical Coherence
3
Standard of Care
3
Niacinamide
3
Microscopy, Confocal
3
IPI-926
3
CTLA-4 Antigen
3
3-ingenyl angelate
3
tazarotene
2
talimogene laherparepvec
2
relatlimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Carcinoma, Basal Cell
×
Laser Speckle Contrast Imaging
×
Clear all
NCT01455363
2025-11-24
HPOB
Institut Curie
Phase NA
Completed
12 enrolled